Yes, the Orphan Drug Regulation 141/2000 cam
Both patients and the public have to be regularly informed about what the use and procedures of H
From diagnosis to treatment and in terms of medicines manufactured, healthcare biotechnology is a
Some 20-30 million Europeans are affected by rare diseases.
The European biotech industry is calling for a robust and transparent framework in which HTA woul